Growth Metrics

Nephros (NEPH) Net Income towards Common Stockholders (2010 - 2026)

Nephros' quarterly Net Income towards Common Stockholders came in at $129000.0 in Q1 2026, down 77.72% year-on-year from $579000.0 in Q1 2025, and up 108.06% quarter-over-quarter from $62000.0 in Q4 2025.

Nephros has reported Net Income towards Common Stockholders for 17 years, with the latest figure at $129000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 77.72% year-over-year to $129000.0; the trailing twelve-month figure through Mar 2026 stood at $765000.0 (down 8.6% YoY), and the FY2025 full-year result was $1.2 million, up 1513.51% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at $129000.0, up from $62000.0 in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $579000.0 in Q1 2025, with the low at -$3.2 million in Q3 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$443000.0, with a median of -$182000.0 recorded in 2023.
  • Year-over-year, Net Income towards Common Stockholders plunged 240.6% in 2022 and jumped 428.98% in 2025.
  • Tracing NEPH's Net Income towards Common Stockholders over 5 years: stood at -$918000.0 in 2022, then grew by 28.76% to -$654000.0 in 2023, then surged by 155.66% to $364000.0 in 2024, then tumbled by 82.97% to $62000.0 in 2025, then surged by 108.06% to $129000.0 in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $129000.0 (Q1 2026), $62000.0 (Q4 2025), and $337000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -274.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 398.73 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 135.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 13.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 130.80 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 112.77 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 2.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 72.77 Mn
10 Nephros 38.93 Mn 34.91 Mn 2.99 Mn 129,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 129,000.00
Dec 31, 2025 62,000.00
Sep 30, 2025 337,000.00
Jun 30, 2025 237,000.00
Mar 31, 2025 579,000.00
Dec 31, 2024 364,000.00
Sep 30, 2024 183,000.00
Jun 30, 2024 -289,000.00
Mar 31, 2024 -176,000.00
Dec 31, 2023 -654,000.00
Sep 30, 2023 -182,000.00
Jun 30, 2023 -433,000.00
Mar 31, 2023 -306,000.00
Dec 31, 2022 -918,000.00
Sep 30, 2022 -3.23 Mn
Jun 30, 2022 -1.20 Mn
Mar 31, 2022 -2.03 Mn
Dec 31, 2021 -1.10 Mn
Sep 30, 2021 -1.22 Mn
Jun 30, 2021 -1.19 Mn
Mar 31, 2021 -596,000.00
Dec 31, 2020 -820,000.00
Sep 30, 2020 -1.07 Mn
Jun 30, 2020 -1.72 Mn
Mar 31, 2020 -1.16 Mn
Dec 31, 2019 -205,000.00
Sep 30, 2019 -804,000.00
Jun 30, 2019 -1.00 Mn
Mar 31, 2019 -1.41 Mn
Dec 31, 2018 -754,000.00
Sep 30, 2018 -542,000.00
Jun 30, 2018 -680,000.00
Mar 31, 2018 -1.21 Mn
Dec 31, 2017 -486,000.00
Sep 30, 2017 -605,000.00
Jun 30, 2017 -763,000.00
Mar 31, 2017 -670,000.00
Dec 31, 2016 -671,000.00
Sep 30, 2016 -701,000.00
Jun 30, 2016 -835,000.00
Mar 31, 2016 -836,000.00
Dec 31, 2015 -948,000.00
Sep 30, 2015 -1.10 Mn
Jun 30, 2015 -1.82 Mn
Mar 31, 2015 -766,000.00
Dec 31, 2014 -996,000.00
Sep 30, 2014 -706,000.00
Jun 30, 2014 -653,000.00
Mar 31, 2014 -757,000.00
Dec 31, 2013 -1.17 Mn
Sep 30, 2013 -613,000.00
Jun 30, 2013 -1.28 Mn
Mar 31, 2013 1.51 Mn
Dec 31, 2012 -1.11 Mn
Sep 30, 2012 -853,000.00
Jun 30, 2012 -811,000.00
Mar 31, 2012 -555,000.00
Dec 31, 2011 -640,000.00
Sep 30, 2011 -423,000.00
Jun 30, 2011 -597,000.00
Mar 31, 2011 -658,000.00
Dec 31, 2010 -604,000.00
Sep 30, 2010 -393,000.00
Jun 30, 2010 -365,000.00